|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$82,211.00 |
2.78% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$81,125.65 |
2.75% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$76,218.15 |
2.58% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$75,336.49 |
2.55% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$74,645.40 |
2.53% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,156.95 |
2.48% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$71,266.71 |
2.41% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$69,106.23 |
2.34% |
| Waters Corporation |
WAT |
941848103 |
184 |
$68,985.28 |
2.34% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$66,984.33 |
2.27% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$66,063.39 |
2.24% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$65,622.54 |
2.22% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$65,611.50 |
2.22% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$65,218.72 |
2.21% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$65,048.74 |
2.20% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$64,921.19 |
2.20% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$63,917.25 |
2.16% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$63,106.56 |
2.14% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$63,164.22 |
2.14% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$62,399.03 |
2.11% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$62,244.90 |
2.11% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$61,628.40 |
2.09% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,495.24 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$59,923.99 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$59,244.75 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$59,164.16 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,456.80 |
1.98% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$57,058.62 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,441.32 |
1.91% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,377.94 |
1.91% |
| Steris Plc |
STE |
G8473T100 |
265 |
$56,036.90 |
1.90% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$54,955.82 |
1.86% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$54,773.19 |
1.86% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$55,060.56 |
1.86% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$54,397.72 |
1.84% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$53,063.17 |
1.80% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$52,490.76 |
1.78% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$51,980.56 |
1.76% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$51,292.06 |
1.74% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$51,231.06 |
1.74% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$51,484.89 |
1.74% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,002.40 |
1.73% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$51,221.12 |
1.73% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$50,566.10 |
1.71% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$47,784.00 |
1.62% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$45,961.62 |
1.56% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,908.33 |
1.55% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$42,050.08 |
1.42% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,103.20 |
1.39% |
| US Dollar |
$USD |
|
14,835 |
$14,834.64 |
0.50% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|